Genedrive PLC (LSE:GDR) - Share price - Overview

Stock Report

Genedrive PLC GDR

Last Price
GBX24.50

Day Change
0.00|0.00%

As of 14/02/2019
12:16:02 GMT | GBX
Minimum 15 Minutes Delay.

Last Close24.50p
Day Range23.00 - 23.00
Mkt Cap8.33Mil
52-Wk Range18.00 - 42.00
Yield %-
ISINGB00B1VKB244
Volume149
P/E-0.89
P/S0.02
P/CF-0.02

Share Price

Total Returns 15/02/2019

 Chg (%)  
More ...
Genedrive PLC12.90 
FTSE 100 TR GBP5.30
 
Financials
201620172018
More ...
Income Statement
Turnover5.062.621.94
Operating Profit-5.43-5.00-5.26
Net Profit-5.92-6.59-7.03
Reported EPS-56.20-35.70-37.60
Balance Sheet
Current Assets4.878.445.40
Non Current Assets6.993.610.51
Total Assets11.8612.055.91
Current Liabilities1.862.162.72
Total Liabilities8.108.618.35
Total Equity3.753.44-2.44
Cash Flow
Operating Cash Flow-4.19-2.59-3.77
Net Change in Cash-4.014.13-1.60

Regulatory News

DateSourceHeadline
More ...
16/01/2019|13:21RNSGenedrive PLC - Holding(s) in Company
15/01/2019|07:00RNSGenedrive PLC - Trading update
31/12/2018|11:30RNSGenedrive PLC - Result of AGM
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/12/2018PurchaseDr. Ian David Gilham23.00152,17435,000.00
10/12/2018PurchaseMr. Chris Henry Francis Yates23.0016,3043,750.00
10/12/2018PurchaseDavid Budd23.00114,13026,250.00
10/12/2018PurchaseMatthew John Fowler23.0086,95720,000.00

Company Profile

Genedrive PLC is a holding company engaged in molecular diagnostics business. The company is organised into operating divisions – Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Sector

Diagnostics & Research

Index

FTSE AIM All-Share

Next Event 28/03/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-234.76
Op Mrgn-2.72
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerDavid Budd
Non-Executive DirectorDr. Roger Lloyd
Non-Executive Director, ChairmanDr. Ian David Gilham
Non-Executive DirectorDr. Robert Dwyer Nolan
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.